PipelineTM Vantage Embolization Device with Shield TechnologyTM PED3-027-500-14Recalls & reported problems
Micro Therapeutics, Inc. · STENT PED3-027-500-14 V03 VANTAGE · Class 3 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00847536036895), received between May 6, 2024 and May 6, 2024 — classified as 1 malfunction.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).
1 FDA recall record name this device's identifier, 1 still open.
11 other recalls cover devices cleared under the same FDA submission (P100018); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- Jan 30, 2025Class IOpen, Classified
Use of embolization device with diameters greater-than-or-equal-to 4mm may lead to incomplete wall apposition and/or braid deformation (fish-mouthing/braid narrowing/braid collapse) noted during procedure and post-procedure, typically noted at 6-12 month imaging follow-up, potentially can lead to thrombosis and/or serious adverse events. Higher risk in females less-than-or-equal-to 45 years of age
Z-1245-2025 · Root cause: Device Design · Recall details · FDA record ↗
Most reported problems
Device problems
- Device Dislodged or Dislocated1
- Structural Problem1
Patient problems
- Failure of Implant1
- Muscle Weakness/Atrophy1
- Nervous System Injury1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 6, 2024Structural Problem; Device Dislodged or Dislocated; Structural Problem; Device Dislodged or Dislocated
MEDTRONIC RECEIVED A REPORT THAT THE DEVICE WAS PLACED CORRECTLY AND PHYSICIAN WAS PLEASED, POST PLACEMENT. 5 HOURS POST PROCEDURE, PATIENT EXHIBITED STROKE LIKE SYMPTOMS, WITH WEAKNESS AND PHYSICIAN BROUGHT THE PATIENT BACK INTO THE IR LAB. IMAGING SHOWED FORESHORTENING ON THE PROXIMAL PORTION OF THE PIPELINE AS WELL AS FISH-MOUTHING. THE BRAIN ALSO APPEARED TO PRO-LAPSE INTO THE AN. THERE WAS MIGRATION AFTER DEPLOYMENT WITH AN UNKNOWN CAUSE. THE PIPELINE WAS IMPLANTED AT THE INTENDED LOCATION AND FULL WALL APPOSITION WAS ACHIEVED. A-CHOROIDAL SIDE BRANCH COVERED BY THE PIPELINE. THE PIPELINE WAS USED FOR AN APPROVED INDICATION. THE DEVICE AND ANY ACCESSORIES WERE PREPARED AS INDICATED IN THE IFU. THE PATIENT WAS UNDERGOING SURGERY FOR TREATMENT OF A BI-LOBAL, UNRUPTURED LEFT DISTAL INTERNAL CAROTID ARTERY (ICA), PARA A-CHOROIDAL ANEURYSM WITH A MAX DIAMETER OF 5.87MM. THE LANDING ZONE WAS 2.88MM DISTALLY AND 2.5MM PROXIMALLY. IT WAS NOTED THE PATIENT'S VESSEL TORTUOSITY WAS MODERATE. DUAL ANTIPLATELET THERAPY (DAPT) WAS ADMINISTERED. ANCILLARY DEVICES INCLUDE A BMX81 GUIDE CATHETER, ARISTOTLE 18 GUIDEWIRE.
Patient problems: Failure of Implant; Muscle Weakness/Atrophy; Nervous System Injury
MAUDE report 19249375 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P100018. One submission often covers many models, so check the product and lot details in each record.
- Z-1246-2025 · Jan 30, 2025 · Open, ClassifiedMedtronic Pipeline Vantage Embolization Device with Shield Technology, REF: PED3-021-350-16, PED3-021-250-14, PED3-021-350-20, PED3-021-250-20, PED3-021-300-16, PED3-021-300-20, PE
- Z-2403-2021 · Jul 13, 2021 · Open, ClassifiedEV3 Pipeline Flex Embolization Device with Flex Shield Technology
- Z-2402-2021 · Jul 13, 2021 · Open, ClassifiedPipeline Flex Embolization Device
- Z-1527-2020 · Feb 14, 2020 · Terminatedev3 Pipeline Flex Embolization Device. For neurological endovascular use.
- Z-0308-2017 · Oct 5, 2016 · TerminatedAlligator Retrieval Device The device is intended for use in the peripheral and neurovasculature for foreign body removal. Catalog No. FA-88810-20V04 FA-88810-20V06 FA-88810-30V04
- Z-0307-2017 · Oct 5, 2016 · TerminatedPipeline Embolization Device (Pipeline Classic) The device is indicated for the endovascular treatment of adults (22 year of age or older) with large or giant widenecked intracrani
- Z-0309-2017 · Oct 5, 2016 · TerminatedMarathon Flow Directed Micro Catheter, UltraFlow HPC Flow Directed Micro Catheter Marathon Flow: The device is intended to access periphera and neurovasculature for the controlled
- Z-0310-2017 · Oct 5, 2016 · TerminatedX-Celerator Hydrophilic Exchange Guidewire Catalog No. 103-0601-300 103-0601-350V10 103-0602-350V06 103-0601-300V01 103-0602-300 103-0602-350V09 103-0601-300V02 103-0602-300V01 10
- Z-0120-2016 · Sep 4, 2015 · Terminated-Pipeline Embolization Device -Pipeline Flex Embolization Device The Pipeline and Pipeline Flex Embolization Devices consist of a permanent implant combined with a guidewire based
- Z-1453-2014 · Apr 1, 2014 · TerminatedPipeline Embolization Device (PED). Used endovascular treatment of adults with intracranial aneurysms in the internal carotid artery.
- Z-2045-2013 · Jul 19, 2013 · TerminatedPipeline Embolization Device (PED) The Pipeline Embolization Device is indicated for the endovascular treatment of adults (22 years of age and older) with large or giant wide-neck
Other Intracranial aneurysm flow diverter devices
- Pipeline TM Flex Embolization Device with Shield Technology TM PED2-300-12Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter2 recalls1 report
- PIPELINE PED-500-20Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall31 reports
- PIPELINE PED-500-35Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall1 death29 reports
- PIPELINE PED-500-16Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall2 deaths27 reports
- PIPELINE PED-500-25Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall1 death23 reports
- PIPELINE PED-500-30Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall21 reports
- PIPELINE PED-450-25Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall20 reports
- PIPELINE PED-475-30Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall1 death19 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page